| |
DOG Congress Home
Invitation
Organization, Deadlines
Overview of the Congress
Scientific Programme
Opening Ceremony
Ceremony 150 Years of DOG
Thursday, 20.September
Friday, 21.September
Saturday, 22.September
Sunday, 23.September
Poster Sessions
Symposia
Courses
Satellite Programme
Information
Social Programme
Sponsors, Exhibitors
DOG Homepage
|
|
AbstractDO.17.03 Treatment of keratoconus with x-linking Kohlhaas M. Department of Ophthalmology, St Johannes-Hospital, Dortmund Objective: The keratoconus is a progressive corneal disease, which is combined with a steepening, a myopic, a thinning out and an irregular astigmatism. Methods: After removal of the epithelium (8mm Ø), riboflavin is seeped on the cornea and than irradiated with UVA-light (370 nm, 3 mW/cm2) at a distance of 1 cm for 30 minutes. 90 eyes from 67 patients (31,47±10,7 years) with a progressive keratoconus were operated with the collagen-crosslinking by using riboflavin/UVA-light. For the pre- and post-controls corneal topography, pachymetrie, tensio, refraction and the visual acuity testing were examined. Results: The postoperative follow-up time was between 1 to 62 months (18,07±15,25). The K-values showed a significant progressive preoperative. Postoperative by 64.4% was the astigmatism reduced for 1,99±2,4 D (0,01 to 12,44). The best-corrected visual acuity increased by 0,62±2,23 lines. No side effects were observed. Conclusions: The collagen-crosslinking at a keratoconus is an efficient method to increase the corneal stability and strength. This operation should be performed by every keratoconus progression, which would reduce the numbers of keratoplasties.
|
|